CA2581023A1 - N-methyl hydroxyethylamine utile dans le traitement d'affections du systeme nerveux central - Google Patents

N-methyl hydroxyethylamine utile dans le traitement d'affections du systeme nerveux central Download PDF

Info

Publication number
CA2581023A1
CA2581023A1 CA002581023A CA2581023A CA2581023A1 CA 2581023 A1 CA2581023 A1 CA 2581023A1 CA 002581023 A CA002581023 A CA 002581023A CA 2581023 A CA2581023 A CA 2581023A CA 2581023 A1 CA2581023 A1 CA 2581023A1
Authority
CA
Canada
Prior art keywords
6alkyl
alkyl
heteroaryl
compound
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002581023A
Other languages
English (en)
Inventor
Edward Fox Kleinman
John Charles Murray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2581023A1 publication Critical patent/CA2581023A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA002581023A 2004-09-21 2005-09-09 N-methyl hydroxyethylamine utile dans le traitement d'affections du systeme nerveux central Abandoned CA2581023A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61177704P 2004-09-21 2004-09-21
US60/611,777 2004-09-21
PCT/IB2005/002877 WO2006032999A1 (fr) 2004-09-21 2005-09-09 N-methyl hydroxyethylamine utile dans le traitement d'affections du systeme nerveux central

Publications (1)

Publication Number Publication Date
CA2581023A1 true CA2581023A1 (fr) 2006-03-30

Family

ID=35559297

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002581023A Abandoned CA2581023A1 (fr) 2004-09-21 2005-09-09 N-methyl hydroxyethylamine utile dans le traitement d'affections du systeme nerveux central

Country Status (7)

Country Link
US (1) US20080132552A1 (fr)
EP (1) EP1794114A1 (fr)
JP (1) JP2008513432A (fr)
BR (1) BRPI0515528A (fr)
CA (1) CA2581023A1 (fr)
MX (1) MX2007002459A (fr)
WO (1) WO2006032999A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010002994A1 (fr) 2008-07-01 2010-01-07 Purdue Research Foundation Inhibiteurs de protéase de vih-1 non peptidiques
JP5894574B2 (ja) 2010-04-22 2016-03-30 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
CN102344402B (zh) * 2010-07-30 2015-01-07 中国人民解放军军事医学科学院毒物药物研究所 苯并氮杂环羟乙基胺类化合物、其制备方法和用途
US9428506B2 (en) 2012-04-14 2016-08-30 Intra-Cellular Therapies, Inc. Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
WO2014145192A1 (fr) 2013-03-15 2014-09-18 Intra-Cellular Therapies, Inc. Composés organiques
KR102373288B1 (ko) 2013-12-03 2022-03-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
KR20170012209A (ko) 2014-04-04 2017-02-02 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
CN111689966A (zh) 2014-04-04 2020-09-22 细胞内治疗公司 有机化合物
IL296884B2 (en) 2016-01-26 2024-05-01 Intra Cellular Therapies Inc Condensed heterocyclic converted gamma carbonyls for use in the treatment of central nervous system disorders
HUE055334T2 (hu) 2016-03-25 2021-11-29 Intra Cellular Therapies Inc Szerves vegyületek és azok alkalmazása központi idegrendszeri betegségek kezelésében vagy megelõzésében
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
JP6987868B2 (ja) 2016-12-29 2022-01-05 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
CN116327770A (zh) 2017-03-24 2023-06-27 细胞内治疗公司 新组合物和方法
CA3071119A1 (fr) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. Gamma-carbolines fusionnees a heterocycles substituees pour le traitement ou la prophylaxie de troubles du systeme nerveux central
MX2020000967A (es) 2017-07-26 2020-09-28 Intra Cellular Therapies Inc Compuestos organicos.
CA3102948A1 (fr) 2018-06-08 2019-12-12 Intra-Cellular Therapies, Inc. Nouvelles methodes
AU2019328528A1 (en) 2018-08-31 2021-03-18 Intra-Cellular Therapies, Inc. Novel methods
KR20210052472A (ko) 2018-08-31 2021-05-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1299349B1 (fr) 2000-06-30 2005-08-24 Elan Pharmaceuticals, Inc. Composes pour le traitement de la maladie d'alzheimer
EA200400162A1 (ru) 2001-07-11 2005-06-30 Элан Фармасьютикалз, Инк. N-(3-амино-2-гидроксипропил)замещенные алкиламидные соединения
GB0228410D0 (en) 2002-12-05 2003-01-08 Glaxo Group Ltd Novel Compounds

Also Published As

Publication number Publication date
JP2008513432A (ja) 2008-05-01
US20080132552A1 (en) 2008-06-05
WO2006032999A1 (fr) 2006-03-30
MX2007002459A (es) 2007-05-04
BRPI0515528A (pt) 2008-07-29
EP1794114A1 (fr) 2007-06-13

Similar Documents

Publication Publication Date Title
CA2581023A1 (fr) N-methyl hydroxyethylamine utile dans le traitement d'affections du systeme nerveux central
EP1299352B1 (fr) Composes pour traiter la maladie d'alzheimer
TWI838430B (zh) 作為vanin抑制劑之雜芳族化合物
AU685154B2 (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them
WO2004050609A1 (fr) Urees et carbamates substitues
CA2467749A1 (fr) Piperidines et piperazines 3,4-disubstituees, 3,5-disubstituees et 3,4,5-substituees
TW201725191A (zh) 新穎方法及中間物
DK168005B1 (da) N-acyleret diamidderivat af sure aminosyrer og fremgangsmaade til fremstilling af samme samt et antiulcermiddel indeholdende et saadant derivat
RU2715233C2 (ru) Способ получения производных азотистого иприта
CN110088079A (zh) 用于早期沙卡布曲中间体的新方法
JP2017537097A (ja) 新規なシストバクタミド
US2543345A (en) Method of preparing glutamic acid amides
CA2498269A1 (fr) Aminoethers substitues pour le traitement de la maladie d'alzheimer
JP2004535424A (ja) アルツハイマー病の治療に有用な置換アミノアルコール
IE50176B1 (en) Process for the production of phenylglycyl chloride hydrochlorides
CA2448084A1 (fr) Composes ethylamine hydroxyles aza
CA2580775A1 (fr) N-ethyl hydroxyethylamine utile dans le traitement d'affections du systeme nerveux central
EP1549649B1 (fr) Procede de preparation d'haloalkyle pyrimidines
US3753996A (en) Derivatives of 4-(aminoethanesul-fonylamino)-phenetidine
WO2007110727A2 (fr) Hydroxyethylamines stabilisees par un amide
JPS604835B2 (ja) ネオスラマイシンの製造法
JPH03115272A (ja) マンデル酸誘導体およびその製法
KR20110048336A (ko) 히스톤 디아세틸라제 저해활성을 갖는 6-아미도-ν-하이드록시헥산아마이드 화합물 및 이의 제조방법
MXPA00010274A (en) Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
EP1586556A2 (fr) Composés pour le traitement de la maladie d'Alzheimer

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued